S. Jagan

发表

CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1.

H. Fung, K. Christopherson, S. Gregory, 2012, Experimental hematology.

Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients

P. Venugopal, K. Christopherson, S. Gregory, 2013, Journal of leukocyte biology.

Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine

P. Venugopal, K. Christopherson, M. Larson, 2012, Advances in hematology.

In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice.

C. Bueso-Ramos, L. Boggio, H. Fung, 2011, Experimental hematology.